Truist Financial Corp. closed 5.45% below its 52-week high of $49.06, which the company reached on November 25th.
Truist raised the firm’s price target on Assurant (AIZ) to $250 from $240 and keeps a Buy rating on the shares following quarterly results. The ...
Truist notes that AnaptysBio (ANAB) reported the “much anticipated” results of its Phase 2b trial of rosnilimab for moderate-to-severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results